Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

ClinicalTrials.gov ID: NCT01018173

Public ClinicalTrials.gov record NCT01018173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, double-blind, placebo-controlled parallel arm study will assess efficacy and safety and the effects of taspoglutide on cardiovascular events in patients with inadequately controlled type 2 diabetes mellitus and established cardiovascular disease. Patients will be randomized to receive either taspoglutide subcutaneously (sc) 10mg weekly for 4 weeks followed by 20mg sc weekly, or weekly sc placebo, in addition to background anti-hyperglycemic medication and standard of care treatment for cardiovascular disease. Anticipated time on study treatment is up to 2 years. Target sample size is 2000 patients.

Study identification

NCT ID
NCT01018173
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
2,118 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Type not available)
Primary completion
Jan 2011 (Actual)
Completion
Jan 2011 (Actual)
Last update posted
Nov 2, 2016

2010 – 2011

United States locations

U.S. sites
76
U.S. states
27
U.S. cities
70
Facility City State ZIP Site status
Not listed Phoenix Arizona 85050 —
Not listed Tucson Arizona 85741 —
Not listed Buena Park California 90620 —
Not listed Calabasas California 91302 —
Not listed Fresno California 93720 —
Not listed Santa Ana California 92705 —
Not listed Walnut Creek California 94598 —
Not listed Centennial Colorado 80112 —
Not listed Colorado Springs Colorado 80907 —
Not listed Trumbull Connecticut 06611 —
Not listed Washington D.C. District of Columbia 20010 —
Not listed Clearwater Florida 33765 —
Not listed Delray Beach Florida 33446 —
Not listed Jacksonville Florida 32216 —
Not listed Miami Florida 33126 —
Not listed Ponte Verde Florida 32081 —
Not listed Bloomingdale Illinois 60108 —
Not listed Chicago Illinois 60607 —
Not listed Chicago Illinois 60610 —
Not listed Evansville Indiana 47714 —
Not listed Baltimore Maryland 21204 —
Not listed Oxon Hill Maryland 20745 —
Not listed Jackson Mississippi 39202 —
Not listed St Louis Missouri 63141 —
Not listed North Platte Nebraska 69101 —
Not listed Omaha Nebraska 68131 —
Not listed Las Vegas Nevada 89101 —
Not listed Las Vegas Nevada 89104 —
Not listed Nashua New Hampshire 3063 —
Not listed Toms River New Jersey 08753 —
Not listed Mineola New York 11501 —
Not listed New York New York 10032 —
Not listed Calabash North Carolina 28467 —
Not listed Cary North Carolina 27518 —
Not listed Chapel Hill North Carolina 27514 —
Not listed Charlotte North Carolina 28209 —
Not listed Durham North Carolina 27713 —
Not listed Mooresville North Carolina 28117 —
Not listed Raleigh North Carolina 27607 —
Not listed Bismarck North Dakota 58501 —
Not listed Bismarck North Dakota 58507 —
Not listed Cleveland Ohio 44122 —
Not listed Kettering Ohio 45429 —
Not listed Toledo Ohio 43623 —
Not listed Bend Oregon 97701 —
Not listed Medford Oregon 97504 —
Not listed Portland Oregon 97229 —
Not listed Beaver Pennsylvania 15009 —
Not listed Levittown Pennsylvania 19056 —
Not listed Philadelphia Pennsylvania 19140 —
Not listed Pottstown Pennsylvania 19464 —
Not listed Greer South Carolina 29651 —
Not listed Hickory Grove South Carolina 28602 —
Not listed Bristol Tennessee 37620 —
Not listed Johnson City Tennessee 37604 —
Not listed Austin Texas 78705 —
Not listed Carrollton Texas 75010 —
Not listed Dallas Texas 75220 —
Not listed Dallas Texas 75230 —
Not listed Dallas Texas 75246 —
Not listed Fort Worth Texas 76109 —
Not listed Houston Texas 77070 —
Not listed Irving Texas 75039 —
Not listed North Richland Hills Texas 76180 —
Not listed Richardson Texas 75080 —
Not listed San Antonio Texas 78229-4801 —
Not listed San Antonio Texas 78229 —
Not listed Temple Texas 76508 —
Not listed Salt Lake City Utah 84107 —
Not listed Burke Virginia 22015 —
Not listed Hampton Virginia 23666 —
Not listed Manassas Virginia 20110 —
Not listed Norfolk Virginia 23502 —
Not listed Richmond Virginia 23219 —
Not listed Winchester Virginia 22601 —
Not listed Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 212 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01018173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01018173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →